Creating systems to deliver growth factors that promote blood vessel formation
Development of affinity-based delivery systems for angiogenic growth factors
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF OREGON · NIH-10999212
This study is exploring a new way to help people with chronic diseases or serious injuries heal better by using special proteins that encourage the growth of new blood vessels, making it easier for their bodies to recover.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF OREGON (nih funded) |
| Locations | 1 site (EUGENE, UNITED STATES) |
| Trial ID | NIH-10999212 on ClinicalTrials.gov |
What this research studies
This research focuses on developing advanced delivery systems for angiogenic growth factors, which are proteins that help in the formation of new blood vessels. By using a method that allows for the controlled release of these proteins, the research aims to mimic the natural healing process of tissues. Patients with chronic diseases or severe injuries that disrupt normal healing may benefit from this innovative approach, as it seeks to enhance the body's ability to regenerate healthy blood vessels. The project will utilize specific interactions between small protein domains and therapeutic proteins to ensure that these growth factors are delivered in a timely and effective manner.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from chronic diseases or severe injuries that impair natural healing processes.
Not a fit: Patients with conditions that do not involve issues with blood vessel formation or healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve healing outcomes for patients with chronic diseases or injuries by enhancing blood vessel formation.
How similar studies have performed: Other research has shown promise in using controlled delivery systems for growth factors, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
EUGENE, UNITED STATES
- UNIVERSITY OF OREGON — EUGENE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SVENDSEN, JUSTIN E — UNIVERSITY OF OREGON
- Study coordinator: SVENDSEN, JUSTIN E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.